Control Bionics’ assistive communication tools are now compatible with Apple devices, opening up myriad opportunities Nyrada plans a phase IIa cardioprotection trial Clinuvel scores a (grudging) ...

Control Bionics secures deal with Tobii Dynavox, global leader with augmentative and alternative communication solutions Tobii Dynavox will evaluate Control Bionics’ (ASX:CBL) NeuroNode for a ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics is revolutionizing communication for individuals with complex needs by introducing a range of AI-powered speech-generating devices ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Control Bionics Ltd. has announced ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MILFORD, Ohio and NEW SOUTH WALES, Australia, April 8, 2021 /PRNewswire/ — Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering ...

PERTH, Australia – Med-tech company Control Bionics began trading on the Australian Securities Exchange (ASX:CBL) Dec. 7 in an IPO that saw the company raise AU$15 million (US$11.25 million).

That is: it’s not easy. Initially, the company took a direct-to-retail, do-it-yourself (DIY) approach with its assistive communication tool, Neuronode. Based on surface electro-myography (EMG), ...